AR and prostate neoplasm: One potential explanation for this finding is that liganded AR can negatively regulate its own expression [47]: thus, the loss of AR protein associated with HSP90 inhibition, which occurs in AUY922-treated, ex vivo cultured prostate tumors [26], could de-repress the AR gene.